Carnegie Investment Counsel’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $974K | Sell |
13,935
-3,212
| -19% | -$224K | 0.02% | 309 |
|
|
2025
Q1 | $1.13M | Buy |
17,147
+655
| +4% | +$43.1K | 0.03% | 274 |
|
|
2024
Q4 | $1.08M | Sell |
16,492
-846
| -5% | -$55.4K | 0.03% | 257 |
|
|
2024
Q3 | $1.35M | Buy |
17,338
+69
| +0.4% | +$5.38K | 0.04% | 242 |
|
|
2024
Q2 | $1.35M | Buy |
17,269
+138
| +0.8% | +$10.8K | 0.04% | 240 |
|
|
2024
Q1 | $1.16M | Sell |
17,131
-683
| -4% | -$46.3K | 0.04% | 275 |
|
|
2023
Q4 | $1.2M | Sell |
17,814
-17
| -0.1% | -$1.15K | 0.04% | 259 |
|
|
2023
Q3 | $1.21M | Sell |
17,831
-10
| -0.1% | -$677 | 0.05% | 247 |
|
|
2023
Q2 | $1.28M | Sell |
17,841
-20
| -0.1% | -$1.43K | 0.05% | 255 |
|
|
2023
Q1 | $1.24M | Buy |
17,861
+452
| +3% | +$31.4K | 0.05% | 263 |
|
|
2022
Q4 | $1.18M | Buy |
17,409
+257
| +1% | +$17.4K | 0.05% | 257 |
|
|
2022
Q3 | $941K | Buy |
17,152
+665
| +4% | +$36.5K | 0.04% | 273 |
|
|
2022
Q2 | $1.09M | Sell |
16,487
-250
| -1% | -$16.5K | 0.05% | 249 |
|
|
2022
Q1 | $1.11M | Sell |
16,737
-1,099
| -6% | -$72.9K | 0.04% | 257 |
|
|
2021
Q4 | $1.04M | Buy |
17,836
+102
| +0.6% | +$5.94K | 0.03% | 269 |
|
|
2021
Q3 | $1.07M | Hold |
17,734
| – | – | 0.04% | 239 |
|
|
2021
Q2 | $1.06M | Buy |
+17,734
| New | +$1.06M | 0.04% | 246 |
|
|
2020
Q4 | – | Sell |
-3,670
| Closed | -$201K | – | 428 |
|
|
2020
Q3 | $201K | Buy |
+3,670
| New | +$201K | 0.01% | 395 |
|
|
2018
Q4 | – | Sell |
-5,972
| Closed | -$244K | – | 370 |
|
|
2018
Q3 | $244K | Buy |
+5,972
| New | +$244K | 0.02% | 316 |
|